Do you want to skip to content? Skip to content
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Convatec

Most visited pages

Reports, results and presentations
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

Reading, United Kingdom (02 March 2018) - Convatec Group Plc ("Convatec") a leading global medical products and technologies company focused on therapies for the management of chronic conditions, today announces the acquisition of J&R Medical LLC ("J&R Medical"), a Texas-based independent distributor of catheter-related supplies. Forthe year ended 31 December 2017 J&R Medical delivered revenues of approximately $9.0 million.

 

Paul Moraviec, CEO of Convatec, said: "The addition of J&R Medical to our Home Distribution Group will strengthen our presence in a substantial and important US market. The acquisition also reinforces Convatec's position as a leading distributor of urinary catheters in the US."

 

Concurrently with this strategic addition to the US Home Distribution Group, Convatec has divested its respiratory delivery business in Arizona and Utah. The net financial impact to Convatec of these transactions is positive in both revenue and EBITDA.

 

Enquiries

 

Media

 

Bobby Leach, VP Group Corporate Affairs, Convatec +44 (0)7770 842 226

Alastair Elwen, Finsbury +44 (0)207 251 3801

 

Analysts and Investors

 

John Crosse, VP Investor Relations, Convatec +44 (0)7500 141 435

Kirsty Law, Director Investor Relations, Convatec +44 (0)7470 909 582

investorrelations@convatec.com

 

About Convatec

 

Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Convatec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about Convatec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

Download PRESS RELEASE

PDF Download

Press Release

See all

5/13/2022

5/13/2022

Q1 Trading Update for the three months ended 31 March 2018

Q1 Trading Update for the three months ended 31 March 2018

Read more

5/13/2022

5/13/2022

Convatec announces changes within its U.S. Home Distribution Group

Convatec announces changes within its U.S. Home Distribution Group

Read more

5/13/2022

5/13/2022

Convatec announces 2018 Interim Results

Convatec announces 2018 Interim Results

Read more

5/13/2022

5/13/2022

03 July 2018 - Board Changes

03 July 2018 - Board Changes

Read more

5/13/2022

5/13/2022

Convatec Receives U.S. FDA 510(k) Clearance for Avelle™ Negative Pressure Wound Therapy System

Convatec Receives U.S. FDA 510(k) Clearance for Avelle™ Negative Pressure Wound Therapy System

Read more

5/13/2022

5/13/2022

Trading update for the three months ended 30 September 2018 and change in FY 2018 guidance

Trading update for the three months ended 30 September 2018 and change in FY 2018 guidance

Read more

5/13/2022

5/13/2022

Retirement of Chief Executive Officer and appointment of Rick Anderson as Chief Executive Officer (Interim)

Retirement of Chief Executive Officer and appointment of Rick Anderson as Chief Executive Officer (Interim)

Read more

5/13/2022

5/13/2022

US FDA 510(k) clearance for AQUACEL™ Ag Advantage

US FDA 510(k) clearance for AQUACEL™ Ag Advantage

Read more

5/13/2022

5/13/2022

Convatec Welcomes Wound Care Sector Deal

Convatec Welcomes Wound Care Sector Deal

Read more